1,071
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Capecitabine-induced oromandibular dystonia: A case report and literature review

, , , &
Pages 1161-1165 | Received 19 Aug 2007, Published online: 08 Jul 2009

Figures & data

Figure 1a & b. 

Figure 1a & b. 

Figure 2a & b.  Axial diffusion- (a & b) and T2- (a & b) weighted images showing restricted diffusion and T2 signal hyperintensity involving the corona radiata (arrows) and splenium of the corpus callosum (arrowheads) in a symmetrical manner at initial presentation.

Figure 2a & b.  Axial diffusion- (Figure 1a & b) and T2- (Figure 2a & b) weighted images showing restricted diffusion and T2 signal hyperintensity involving the corona radiata (arrows) and splenium of the corpus callosum (arrowheads) in a symmetrical manner at initial presentation.

Figure 3a & b.  Follow-up MR study performed a month later shows resolution of the previously noted T2W signal hyperintensity in the corona radiata with some residual T2W signal hyperintensity seen in the splenium of the corpus callosum (arrowheads).

Figure 3a & b.  Follow-up MR study performed a month later shows resolution of the previously noted T2W signal hyperintensity in the corona radiata with some residual T2W signal hyperintensity seen in the splenium of the corpus callosum (arrowheads).

Table I.  Summary of case reports on capecitabine-induced multifocal leukoencephalopathy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.